Elisa Stasi

Administration Timing Is the Best Clinical Outcome Predictor for Adalimumab Administration in Crohn's Disease

Mastronardi, M., Curlo, M., Cavalcanti, E., Burattini, O., Cuppone, R., Tauro, R., De Santis, S., Serino, G., Pesole, P. L., Stasi, E., Caruso, M. L., Donghia, R., Guerra, V., Giorgio, P. & Chieppa, M., Nov 1 2019, In : Frontiers in Medicine. 6, 234.

Research output: Contribution to journal › Article

Open Access

Crohn Disease

Anti-Idiotypic Antibodies

Retrospective Studies

Adalimumab

Therapeutics

Five common errors to avoid in clinical practice: the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) Choosing Wisely Campaign

Stasi, E., Michielan, A., Morreale, G. C., Tozzi, A., Venezia, L., Bortoluzzi, F., Triossi, O., Soncini, M., Leandro, G., Milazzo, G. & Anderloni, A., Mar 2019, In : Internal and Emergency Medicine. 14, 2, p. 301-308 8 p.

Research output: Contribution to journal › Article

Colonoscopy

Polyps

Digestive System Endoscopy

Occult Blood

Modern 1601-history

Iatrogenic Kaposi sarcoma of the terminal ileum following short-term treatment with immunomodulators for Crohn disease: A case report

Stasi, E., De Santis, S., Cavalcanti, E. & Armentano, R., May 2019, In : Medicine. 98, 20, p. e15714

Research output: Contribution to journal › Article

Kaposi's Sarcoma

Immunologic Factors

Ileum

Crohn Disease

Immunosuppressive Agents

Long-term safety of in utero exposure to anti-TNFα drugs for the treatment of inflammatory bowel disease: Results from the multicenter European TEDDY study

Chaparro, M., Verreth, A., Lobaton, T., Gravito-Soares, E., Julsgaard, M., Savarino, E., Magro, F., Biron, I. A., Lopez-Serrano, P., Casanova, M. J., Gompertz, M., Vitor, S., Arroyo, M., Pugliese, D., Zabana, Y., Vicente, R., Aguas, M., Shitrit, A. B. G., Gutierrez, A., Doherty, G. A. & 30 others, Fernandez-Salazar, L., Cadilla, J. M., Huguet, J. M., O’Toole, A., Stasi, E., Marcos, N. M., Villoria, A., Karmiris, K., Rahier, J. F., Rodriguez, C., Diz-Lois Palomares, M., Fiorino, G., Benitez, J. M., Principi, M., Naftali, T., Taxonera, C., Mantzaris, G., Sebkova, L., Iade, B., Lissner, D., Bradley, I. F., Roman, A. L. S., Marin-Jimenez, I., Merino, O., Sierra, M., Van Domselaar, M., Caprioli, F., Guerra, I., Peixe, P. & Piqueras, M., Mar 1 2018, In : American Journal of Gastroenterology. 113, 3, p. 396-403 8 p.

Research output: Contribution to journal › Article

Inflammatory Bowel Diseases

Tumor Necrosis Factor-alpha

Safety

Pharmaceutical Preparations

Infection

Long-term safety of in utero exposure to anti-TNFα drugs for the treatment of inflammatory bowel disease: Results from the Multicenter European TEDDY Study

Chaparro, M., Verreth, A., Lobaton, T., Gravito-Soares, E., Julsgaard, M., Savarino, E., Magro, F., Biron, I. A., Lopez-Serrano, P., Casanova, M. J., Gompertz, M., Vitor, S., Arroyo, M., Pugliese, D., Zabana, Y., Vicente, R., Aguas, M., Shitrit, A. B. G., Gutierrez, A., Doherty, G. A. & 30 others, Fernandez-Salazar, L., Cadilla, J. M., Huguet, J. M., O’Toole, A., Stasi, E., Marcos, N. M., Villoria, A., Karmiris, K., Rahier, J. F., Rodriguez, C., Diz-Lois Palomares, M., Fiorino, G., Benitez, J. M., Principi, M., Naftali, T., Taxonera, C., Mantzaris, G., Sebkova, L., Iade, B., Lissner, D., Bradley, I. F., Roman, A. L. S., Marin-Jimenez, I., Merino, O., Sierra, M., Van Domselaar, M., Caprioli, F., Guerra, I., Peixe, P. & Piqueras, M., Mar 1 2018, In : American Journal of Gastroenterology. 113, 3, p. 396-403 8 p.

Research output: Contribution to journal › Article

Inflammatory Bowel Diseases

Tumor Necrosis Factor-alpha

Safety

Pharmaceutical Preparations

Infection

Elisa Stasi

Fingerprint Dive into the research topics where Elisa Stasi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2016 2019

Administration Timing Is the Best Clinical Outcome Predictor for Adalimumab Administration in Crohn's Disease

Five common errors to avoid in clinical practice: the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) Choosing Wisely Campaign

Iatrogenic Kaposi sarcoma of the terminal ileum following short-term treatment with immunomodulators for Crohn disease: A case report

Long-term safety of in utero exposure to anti-TNFα drugs for the treatment of inflammatory bowel disease: Results from the multicenter European TEDDY study

Long-term safety of in utero exposure to anti-TNFα drugs for the treatment of inflammatory bowel disease: Results from the Multicenter European TEDDY Study